ANTHERA PHARMACEUTICALS INC's ticker is ANTH and the CUSIP is 03674U201. A total of 74 filers reported holding ANTHERA PHARMACEUTICALS INC in Q2 2016. The put-call ratio across all filers is 19.84 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $38,000 | -79.3% | 58,500 | 0.0% | 0.00% | -81.8% |
| Q3 2016 | $184,000 | -1.1% | 58,500 | -2.7% | 0.01% | -21.4% |
| Q2 2016 | $186,000 | -49.2% | 60,143 | -40.5% | 0.01% | -12.5% |
| Q1 2016 | $366,000 | -22.0% | 101,000 | 0.0% | 0.02% | -50.0% |
| Q4 2015 | $469,000 | -23.7% | 101,000 | 0.0% | 0.03% | +18.5% |
| Q3 2015 | $615,000 | -28.7% | 101,000 | +1.0% | 0.03% | -20.6% |
| Q2 2015 | $862,000 | +75.2% | 100,000 | -9.1% | 0.03% | +54.5% |
| Q1 2015 | $492,000 | +48.2% | 110,000 | -47.6% | 0.02% | +100.0% |
| Q4 2014 | $332,000 | -17.6% | 210,000 | 0.0% | 0.01% | +10.0% |
| Q3 2014 | $403,000 | -43.4% | 210,000 | 0.0% | 0.01% | -33.3% |
| Q2 2014 | $712,000 | +1.1% | 210,000 | 0.0% | 0.02% | +7.1% |
| Q1 2014 | $704,000 | +9.1% | 210,000 | 0.0% | 0.01% | 0.0% |
| Q4 2013 | $645,000 | -61.8% | 210,000 | -50.0% | 0.01% | -22.2% |
| Q3 2013 | $1,688,000 | – | 420,000 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ProQuest Associates IV LLC | 1,250,000 | $1,975,000 | 1.00% |
| Broadfin Capital, LLC | 3,567,624 | $5,636,000 | 0.24% |
| Abingworth LLP | 437,994 | $679,000 | 0.19% |
| GREAT POINT PARTNERS LLC | 250,000 | $395,000 | 0.19% |
| Rhenman & Partners Asset Management AB | 400,000 | $632,000 | 0.18% |
| BVF INC/IL | 559,624 | $884,000 | 0.17% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,691,857 | $2,673,000 | 0.10% |
| Perceptive Advisors | 503,156 | $795,000 | 0.07% |
| Gruss Capital Management LP | 960,000 | $1,517,000 | 0.04% |
| Spark Investment Management LLC | 103,400 | $160,000 | 0.03% |